Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 2
1977 1
1978 4
1979 5
1980 2
1981 3
1982 3
1983 3
1984 4
1985 6
1986 2
1987 8
1988 4
1989 3
1990 2
1991 1
1992 2
1993 1
1994 1
1995 1
2001 1
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
DNA topoisomerases in cancer therapy.
Lock RB, Ross WE. Lock RB, et al. Among authors: ross we. Anticancer Drug Des. 1987 Oct;2(2):151-64. Anticancer Drug Des. 1987. PMID: 2835059 Review.
Resistance to inhibitors of DNA topoisomerases.
Sullivan DM, Ross WE. Sullivan DM, et al. Among authors: ross we. Cancer Treat Res. 1991;57:57-99. doi: 10.1007/978-1-4615-3872-1_4. Cancer Treat Res. 1991. PMID: 1686723 Review.
Unconventional cancer therapy.
Ross WE. Ross WE. Compr Ther. 1985 Sep;11(9):37-43. Compr Ther. 1985. PMID: 4042595 No abstract available.
Inhibition of topoisomerases by fredericamycin A.
Latham MD, King CK, Gorycki P, Macdonald TL, Ross WE. Latham MD, et al. Among authors: ross we. Cancer Chemother Pharmacol. 1989;24(3):167-71. doi: 10.1007/BF00300237. Cancer Chemother Pharmacol. 1989. PMID: 2544307
Paraquat-induced DNA damage in mammalian cells.
Ross WE, Block ER, Chang RY. Ross WE, et al. Biochem Biophys Res Commun. 1979 Dec 28;91(4):1302-8. doi: 10.1016/0006-291x(79)91208-7. Biochem Biophys Res Commun. 1979. PMID: 526305 No abstract available.
Planning for discovery.
Ross WE. Ross WE. J Fla Med Assoc. 1992 Sep;79(9):603-4. J Fla Med Assoc. 1992. PMID: 1431789 No abstract available.
61 results